Evidence map›Paper›PMID 33060082›Full record

ArticleBMJ open2020

EnDPoINT: protocol for an implementation research study to integrate a holistic package of physical health, mental health and psychosocial care for podoconiosis, lymphatic filariasis and leprosy into routine health services in Ethiopia.

Maya Semrau, Oumer Ali, Kebede Deribe, Asrat Mengiste, Abraham Tesfaye, Mersha Kinfe, Stephen A Bremner, Natalia Hounsome, Louise A Kelly-Hope, Hayley MacGregor and 6 more

Open access · goldAbstract read
In one paragraph

Article in BMJ open, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Podoconiosis: key priorities for research and implementation.Transactions of the Royal Society of Tropical Medicine and Hygiene · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 6 institutions in 2 countries.

Maya SemrauCentre for Global Health Research, Brighton and Sussex Medical School, Brighton, UK m.semrau@bsms.ac.uk.ORCID 0000-0003-0366-1093
Oumer AliCentre for Global Health Research, Brighton and Sussex Medical School, Brighton, UK.
Kebede DeribeCentre for Global Health Research, Brighton and Sussex Medical School, Brighton, UK.
Asrat MengisteCenter for Innovative Drug Development and Therapeutic Trials for Africa (CDT-Africa), Addis Ababa University, Addis Ababa, Ethiopia.
Abraham TesfayeCenter for Innovative Drug Development and Therapeutic Trials for Africa (CDT-Africa), Addis Ababa University, Addis Ababa, Ethiopia.
Mersha KinfeCenter for Innovative Drug Development and Therapeutic Trials for Africa (CDT-Africa), Addis Ababa University, Addis Ababa, Ethiopia.
Stephen A BremnerDepartment of Primary Care and Public Health, Brighton and Sussex Medical School, Brighton, UK.
Natalia HounsomeCentre for Global Health Research, Brighton and Sussex Medical School, Brighton, UK.
Louise A Kelly-HopeCentre for Neglected Tropical Diseases, Department of Tropical Disease Biology, Liverpool School of Tropical Medicine, Liverpool, UK.
Hayley MacGregorHealth and Development Cluster, Institute of Development Studies, University of Sussex, Brighton, UK.
Henock B TaddeseFaculty of Medicine, School of Public Health, Imperial College London, London, UK.
Hailom BanteyergaCollege of Humanities, Language Studies, Journalism and Communication, Addis Ababa University, Addis Ababa, Ethiopia.
Damen HaileMariamSchool of Public Health, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.
Nebiyu NegussuNeglected Tropical Diseases, Disease Prevention and Control Directorate, Federal Ministry of Health, Addis Ababa, Ethiopia.
Abebaw FekaduCentre for Global Health Research, Brighton and Sussex Medical School, Brighton, UK.ORCID 0000-0003-2219-0952
Gail DaveyCentre for Global Health Research, Brighton and Sussex Medical School, Brighton, UK.
Brighton and Sussex Medical School · GBAddis Ababa University · ETFederal Ministry of Health · ETImperial College London · GBLiverpool School of Tropical Medicine · GBUniversity of Sussex · GB

Funding

Medical Research Council MR/M025470/1Wellcome Trust 201900/Z/16/Z
6 · The paper itself

Abstract

introductionNeglected tropical diseases (NTDs) causing lower limb lymphoedema such as podoconiosis, lymphatic filariasis (LF) and leprosy are common in Ethiopia. Routine health services for morbidity management and disability prevention (MMDP) of lymphoedema caused by these conditions are still lacking, even though it imposes a huge burden on affected individuals and their communities in terms of physical and mental health, and psychosocial and economic outcomes. This calls for an integrated, holistic approach to MMDP across these three diseases. METHODS AND ANALYSIS: The 'Excellence in Disability Prevention Integrated across NTDs' (EnDPoINT) implementation research study aims to assess the integration and scale-up of a holistic package of care-including physical health, mental health and psychosocial care-into routine health services for people with lymphoedema caused by podoconiosis, LF and leprosy in selected districts in Awi zone in the North-West of Ethiopia. The study is being carried out over three phases using a wide range of mixed methodologies. Phase 1 involves the development of a comprehensive holistic care package and strategies for its integration into the routine health services across the three diseases, and to examine the factors that influence integration and the roles of key health system actors. Phase 2 involves a pilot study conducted in one subdistrict in Awi zone, to establish the care package's adoption, feasibility, acceptability, fidelity, potential effectiveness, its readiness for scale-up, costs of the interventions and the suitability of the training and training materials. Phase 3 involves scale-up of the care package in three whole districts, as well as its evaluation in regard to coverage, implementation, clinical (physical health, mental health and psychosocial) and economic outcomes. ETHICS AND DISSEMINATION: Ethics approval for the study has been obtained in the UK and Ethiopia. The results will be disseminated through publications in scientific journals, conference presentations, policy briefs and workshops.

Indexed as

ElephantiasisElephantiasis, FilarialLeprosyPsychiatric RehabilitationEthiopiaHealth ServicesHumansMental HealthPilot Projectsimplementation researchleprosylymphatic filariasislymphoedemamental healthpodoconiosis

Identifiers

PMID33060082
PMCPMC7566734
OpenAlexW3092931237

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.